Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes
Top Cited Papers
- 1 April 2003
- journal article
- conference paper
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 31 (4), 421-431
- https://doi.org/10.1124/dmd.31.4.421
Abstract
Cultured human hepatocytes are a valuable in vitro system for evaluating new molecular entities as inducers of cytochrome P450 (P450) enzymes. The present study summarizes data obtained from 62 preparations of cultured human hepatocytes that were treated with vehicles (saline or dimethylsulfoxide, 0.1%), β-naphthoflavone (33 μM), phenobarbital (100 or 250 μM), isoniazid (100 μM) and/or rifampin (20 or 50 μM), and examined for the expression of P450 enzymes based on microsomal activity toward marker substrates, or in the case of CYP2C8, the level of immunoreactive protein. The results show that CYP1A2 activity was markedly induced by β-naphthoflavone (on average 13-fold, n = 28 preparations), and weakly induced by phenobarbital (1.9-fold, n = 25) and rifampin (2.3-fold, n = 22); CYP2A6 activity tended to be increased with phenobarbital (n = 7) and rifampin (n = 3) treatments, but the effects were not statistically significant; CYP2B6 was induced by phenobarbital (6.5-fold, n = 13) and rifampin (13-fold,n = 14); CYP2C8 was induced by phenobarbital (4.0-fold, n = 4) and rifampin (5.2-fold,n = 4); CYP2C9 was induced by phenobarbital (1.8-fold, n = 14) and rifampin (3.5-fold,n = 10); CYP2C19 was markedly induced by rifampin (37-fold, n = 10), but relatively modestly by phenobarbital (7-fold, n = 9); CYP2D6 was not significantly induced by phenobarbital (n = 5) or rifampin (n = 5); CYP2E1 was induced by phenobarbital (1.7-fold, n = 5), rifampin (2.2-fold, n = 5), and isoniazid (2.3-fold,n = 5); and, CYP3A4 was induced by phenobarbital (3.3-fold, n = 42) and rifampin (10-fold,n = 61), but not by β-naphthoflavone. Based on these observations, we generalize that β-naphthoflavone induces CYP1A2 and isoniazid induces CYP2E1, whereas rifampin and, to a lesser extent phenobarbital, tend to significantly and consistently induce enzymes of the CYP2A, CYP2B, CYP2C, CYP2E, and CYP3A subfamilies but not the 2D subfamily.Keywords
This publication has 43 references indexed in Scilit:
- A Cell-Based Reporter Gene Assay for Determining Induction of CYP3A4 in a High-Volume SystemJournal of Pharmacology and Experimental Therapeutics, 2002
- Expression and Induction of CYP2C P450 Enzymes in Primary Cultures of Human HepatocytesJournal of Pharmacology and Experimental Therapeutics, 2002
- Induction of Cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but Not of CYP2C9, CYP2C19, Multidrug Resistance (MDR-1) and Multidrug Resistance Associated Protein (MRP-1) by Prototypical Inducers in Human HepatocytesBiochemical and Biophysical Research Communications, 2000
- Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytesXenobiotica, 2000
- Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophyllineBritish Journal of Clinical Pharmacology, 1999
- The influence of rifampin treatment on caffeine clearance in healthy manJournal of Hepatology, 1995
- Extracellular matrix proteins modulate cytochrome P450 2D6 expression in human hepatocytesJournal of Hepatology, 1995
- Specific and dose-dependent enzyme induction by omeprazole in human beingsHepatology, 1994
- Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptorBiochemical and Biophysical Research Communications, 1992
- Effect of phenobarbital on theophylline dispositionJournal of Allergy and Clinical Immunology, 1978